AboutSign In

Compass Pathways

Organization

Publicly traded biotech company developing synthetic psilocybin (COMP360) for treatment-resistant depression

2 stories

01
health38d ago

Single Dose of Psilocybin Produces Lasting Structural Changes in the Brain, Study Finds

9 min read
02
politics55d ago

Trump Signs Executive Order Directing FDA to Review Psychedelic Breakthrough Therapy Drugs

11 min read